Primary malignant melanoma of the limbs: a re-evaluation using microstaging techniques

Area of Science:

• Oncology
• Dermatology
• Surgical Pathology

Background:

• Malignant melanoma is a significant skin cancer.
• Understanding prognostic factors and treatment efficacy is crucial for patient outcomes.

Purpose of the Study:

• To correlate clinical course with microstaging in limb malignant melanoma.
• To determine if treatment modalities influence disease progression and recurrence.

Main Methods:

• Retrospective review of 256 limb malignant melanoma cases from 1955-1969.
• Analysis of disease recurrence rates based on microstage (Breslow depth) and treatment.

Main Results:

• Recurrence rates increased with melanoma depth: Level II (19%) to Level V (94%).
• Depth-specific recurrence rates ranged from 18% (<0.5 mm) to 74% (>3 mm).
• Early-stage melanomas (Level II or <1 mm Level III) showed no difference in recurrence/survival across treatments (wide excision vs. regional chemotherapy).
• Deeper melanomas demonstrated statistically better recurrence rates, survival, and time to recurrence with regional therapy.

Conclusions:

• Microstaging is a critical prognostic indicator in malignant melanoma.
• Regional therapy offers a significant survival and recurrence benefit for deeper invasive melanomas.
• Treatment selection should be guided by melanoma depth and invasiveness.